An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and ...

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

The race to develop muscle-preserving treatments alongside popular obesity drugs like Eli Lillys (NYSE:LLY) Zepbound and Novo ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...

Viking Therapeutics ( VKTX -0.88%) soared early last year when it reported strong data from the phase 2 trial of its weight ...